- Aug 2
- |
- 2023
Press Release
- Follow Us
CDI LABS NEWS |
- Aug 2, 2023Press Release: Barney E. Saunders Ph.D. has been appointed Chief Executive Officer of CDI La...
- Jan 9, 2023Press Release: BroadOak Capital Partners Invests in CDI Laboratories to Expand and Scale Ant...
- Sep 23, 2020Press Release: CDI Labs HuProt™ Protein Arrays Instrumental in Recent Study of Multisystem...
- Feb 4, 2020Press Release: CDI Labs Launches Two New Powerful Assays to its Biomarker Discovery Platform
What Our Customers Are Saying
"With CDI Labs, identifying antibodies and their targets has never been so simple. Their passionate team, robust science and high-quality service unlock the discovery of new mechanisms, biomarkers and therapeutic targets."
Matthieu Roulleaux DugageGustave Roussy
What Our Customers Are Saying
"We enjoyed working with CDI Labs. We used both VirScan and HuScan services from CDI Labs as part of our neurodegenerative disease research. The team at CDI Labs was very responsive and great to work with, and they went above and beyond to get us our results very quickly. They were particularly helpful in making contract arrangements and ensuring that everything was in place for a smooth collaboration. CDI Labs also provided a comprehensive statistical analysis, which will be invaluable as we build on our research. We’re still analyzing the data, but we’re confident that we’ll gain new insights into disease mechanisms that will advance our research."
What Our Customers Are Saying
"CDI Labs provide consistent service and consistently high-quality protein array products to our lab. Their sales and scientific team are courteous and timely in their responses to our queries.”
Data and Technology Validated by Scientists
"We elected to use the HuProt Microarray because it is an extensive platform that contains over 21,000 unique, individually purified full-length human proteins and protein isoforms in duplicate, covering more than 81% of the proteome."
OncologistSchool of Medicine Research
Data and Technology Validated by Scientists
"This (VirScan) assay, which uses phage display immunoprecipitation and sequencing, is a sensitive and focused high-comprehensive approach that enables thorough serological profiling of antiviral antibodies in humans and, consequently, the identification of viral exposure throughout the human virome."
Faculty of MedicineResearch Institution
Data and Technology Validated by Scientists
"By using (HuProt) protein arrays, we were able to evaluate a broader range of antigens compared to previous investigations."
Senior ScientistBiotech Research
Ask about our products and services
Featured Publications
View all publications- Nov 8
- |
- 2023
/var/www/8romans.com/cdilabs-new/public_html/includes/section-slides/pubs.php on line 83" width="250" height="150" alt="Science Advances" />
on Science Advances
VirScan: Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8+ T cells in patients with advanced NSCLC
Marie Naigeon, Nathalie Chaput, et. al.
- Nov 8
- |
- 2023
/var/www/8romans.com/cdilabs-new/public_html/includes/section-slides/pubs.php on line 83" width="250" height="150" alt="Nature" />
on Nature
HuProt: Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
Tom Le Voyer, Anne Puel, et. al.
- Feb 22
- |
- 2023
/var/www/8romans.com/cdilabs-new/public_html/includes/section-slides/pubs.php on line 83" width="250" height="150" alt="Nature" />
on Nature
HuProt: Autoimmunity in Down’s syndrome via cytokines, CD4 T cells and CD11c+ B cells
Louise Malle, Dusan Bogunovic, et. al.
- Sep 15
- |
- 2022
/var/www/8romans.com/cdilabs-new/public_html/includes/section-slides/pubs.php on line 83" width="250" height="150" alt="AACR - Clinical Cancer Research" />
on AACR - Clinical Cancer Research
HuProt: Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade
Paul Johannet, Iman Osman, et. al.
- Apr 13
- |
- 2022
/var/www/8romans.com/cdilabs-new/public_html/includes/section-slides/pubs.php on line 83" width="250" height="150" alt="Nature Scientific Reports" />
on Nature Scientific Reports
HuProt: Temporal reproducibility of IgG and IgM autoantibodies in serum from healthy women
T. V. Clendenen, Y. Chen, et. al.
- Feb 3
- |
- 2021
/var/www/8romans.com/cdilabs-new/public_html/includes/section-slides/pubs.php on line 83" width="250" height="150" alt="Nature" />
on Nature
HuProt: IgA transcytosis and antigen recognition govern ovarian cancer immunity
Subir Biswas, Jose R. Conejo-Garcia, et. al.
- Mar 19
- |
- 2018
/var/www/8romans.com/cdilabs-new/public_html/includes/section-slides/pubs.php on line 83" width="250" height="150" alt="Nature Methods" />
on Nature Methods
HuProt: A toolbox of immunoprecipitation-grade monoclonal antibodies to human transcription factors
Anand Venkataraman, Blackshaw Seth, et. al.
News
View all news
- Jan 9
- |
- 2023
Press Release
BroadOak Capital Partners Invests in CDI Laboratories to Expand and Scale Antibody Biomarker Discovery Platforms
Read MoreWEBINAR
- Apr 3
- -
- Apr 3
- 10:00 AM PT / 1:00 PM ET